| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
11β-Hydroxysteroid dehydrogenase (11β-HSD) catalyses the metabolism of corticosterone to inert 11-dehydrocorticosterone, thus preventing glucocorticoid access to otherwise non-selective renal mineralocorticoid receptors (MRs), producing aldosterone selectivity in vivo. At least two isoforms of 11β-HSD exist. One isoform (11β-HSD1) has been purified from rat liver and an encoding cDNA cloned from a rat liver library. Transfection of rat 11β-HSD1 cDNA into amphibian cells with a mineralocorticoid phenotype encodes 11 β-reductase activity (activation of inert 11-dehydrocorticosterone) suggesting that 11β-HSD1 does not have the necessary properties to protect renal MRs from exposure to glucocorticoids. This function is likely to reside in a second 11β-HSD isoform. 11β-HSD1 is co-localized with glucocorticoid receptors (GRs) and may modulate glucocorticoid access to this receptor type. To examine the predominant direction of 11β-HSD1 activity in intact mammalian cells, and the possible role of 11β-HSD in regulating glucocorticoid access to GRs, we transfected rat 11β-HSD1 cDNA into a mammalian kidney-derived cell system (COS-7) which has little endogenous 11β-HSD activity or mRNA expression.
Homogenates of COS-7 cells transfected with increasing amounts of 11β-HSD cDNA exhibited a dose-related increase in 11 β-dehydrogenase activity. In contrast, intact cells did not convert corticosterone to 11-dehydrocorticosterone over 24 h, but showed a clear dose-related 11β-reductase activity, apparent within 4 h of addition of 11-dehydrocorticosterone to the medium. To demonstrate that this reflected a change in functional intracellular glucocorticoids, COS-7 cells were co-transfected with an expression vector encoding GR and a glucocorticoid-inducible MMTV-LTR luciferase reporter construct, with or without 11β-HSD. Corticosterone induced MMTV-LTR luciferase expression in the presence or absence of 11β-HSD. 11-Dehydrocorticosterone was without activity in the absence of 11β-HSD, but induced MMTV-LTR luciferase activity in the presence of 11β-HSD. These results indicate that rat 11β-HSD1 can behave exclusively as a reductase in intact mammalian cells. Thus in some tissues in vivo, 11β-HSD1 may regulate ligand access to GRs by reactivating inert glucocorticoids.
This article has been cited by other articles:
|
|
 |
|
  A. Balachandran, H. Guan, M. Sellan, S. van Uum, and K. Yang Insulin and Dexamethasone Dynamically Regulate Adipocyte 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Endocrinology, August 1, 2008; 149(8): 4069 - 4079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. De Sousa Peixoto, S. Turban, J. H. Battle, K. E. Chapman, J. R. Seckl, and N. M. Morton Preadipocyte 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Is a Keto-Reductase and Contributes to Diet-Induced Visceral Obesity in Vivo Endocrinology, April 1, 2008; 149(4): 1861 - 1868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liu, F. Park, J. L. Pietrusz, G. Jia, R. J. Singh, B. C. Netzel, and M. Liang Suppression of 11{beta}-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis Physiol Genomics, February 19, 2008; 32(3): 343 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sunak, D. F Green, L. R Abeydeera, L. M Thurston, and A. E Michael Implication of cortisol and 11{beta}-hydroxysteroid dehydrogenase enzymes in the development of porcine (Sus scrofa domestica) ovarian follicles and cysts Reproduction, June 1, 2007; 133(6): 1149 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Gilmour, A. E. Coutinho, J.-F. Cailhier, T. Y. Man, M. Clay, G. Thomas, H. J. Harris, J. J. Mullins, J. R. Seckl, J. S. Savill, et al. Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes. J. Immunol., June 15, 2006; 176(12): 7605 - 7611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Paterson, J. R. Seckl, and J. J. Mullins Genetic manipulation of 11{beta}-hydroxysteroid dehydrogenases in mice Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R642 - R652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. J Bujalska, N. Draper, Z. Michailidou, J. W Tomlinson, P. C White, K. E Chapman, E. A Walker, and P. M Stewart Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11{beta}-hydroxysteroid dehydrogenase type 1 J. Mol. Endocrinol., June 1, 2005; 34(3): 675 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Tomlinson, E. A. Walker, I. J. Bujalska, N. Draper, G. G. Lavery, M. S. Cooper, M. Hewison, and P. M. Stewart 11{beta}-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response Endocr. Rev., October 1, 2004; 25(5): 831 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Sandeep, J. L. W. Yau, A. M. J. MacLullich, J. Noble, I. J. Deary, B. R. Walker, and J. R. Seckl From The Cover: 11{beta}-Hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics PNAS, April 27, 2004; 101(17): 6734 - 6739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Justesen, L. Mosekilde, M. Holmes, K. Stenderup, J. Gasser, J. J. Mullins, J. R. Seckl, and M. Kassem Mice Deficient in 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Lack Bone Marrow Adipocytes, but Maintain Normal Bone Formation Endocrinology, April 1, 2004; 145(4): 1916 - 1925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue Recent Prog. Horm. Res., January 1, 2004; 59(1): 359 - 393. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. Shafqat, B. Elleby, S. Svensson, J. Shafqat, H. Jornvall, L. Abrahmsen, and U. Oppermann Comparative Enzymology of 11beta -Hydroxysteroid Dehydrogenase Type 1 from Glucocorticoid Resistant (Guinea Pig) Versus Sensitive (Human) Species J. Biol. Chem., January 10, 2003; 278(3): 2030 - 2035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Thompson, V.K.M. Han, and K. Yang Spatial and Temporal Patterns of Expression of 11{beta}-Hydroxysteroid Dehydrogenase Types 1 and 2 Messenger RNA and Glucocorticoid Receptor Protein in the Murine Placenta and Uterus During Late Pregnancy Biol Reprod, December 1, 2002; 67(6): 1708 - 1718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Harris, Y. Kotelevtsev, J. J. Mullins, J. R. Seckl, and M. C. Holmes Intracellular Regeneration of Glucocorticoids by 11{beta}-Hydroxysteroid Dehydrogenase (11{beta}-HSD)-1 Plays a Key Role in Regulation of the Hypothalamic-Pituitary-Adrenal Axis: Analysis of 11{beta}-HSD-1-Deficient Mice Endocrinology, January 1, 2001; 142(1): 114 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Waddell and P. J. Burton Full Induction of Rat Myometrial 11{beta}-Hydroxysteroid Dehydrogenase Type 1 in Late Pregnancy Is Dependent on Intrauterine Occupancy Biol Reprod, April 1, 2000; 62(4): 1005 - 1009. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Weber, S. Lewicka, M. Deuschle, M. Colla, P. Vecsei, and I. Heuser Increased Diurnal Plasma Concentrations of Cortisone in Depressed Patients J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1133 - 1136. [Abstract] [Full Text]
|
|
|
|
|
|
A. Nordenström, C. Marcus, M. Axelson, A. Wedell, and E. M. Ritzén Failure of Cortisone Acetate Treatment in Congenital Adrenal Hyperplasia because of Defective 11{beta}-Hydroxysteroid Dehydrogenase Reductase Activity J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1210 - 1213. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. G. Mensah-Nyagan, J.-L. Do-Rego, D. Beaujean, V. Luu-The, G. Pelletier, and H. Vaudry Neurosteroids: Expression of Steroidogenic Enzymes and Regulation of Steroid Biosynthesis in the Central Nervous System Pharmacol. Rev., March 1, 1999; 51(1): 63 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Burton and B. J. Waddell Dual Function of 11ß-Hydroxysteroid Dehydrogenase in Placenta: Modulating Placental Glucocorticoid Passage and Local Steroid Action Biol Reprod, February 1, 1999; 60(2): 234 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Waddell, R. Benediktsson, R. W. Brown, and J. R. Seckl Tissue-Specific Messenger Ribonucleic Acid Expression of 11{beta}-Hydroxysteroid Dehydrogenase Types 1 and 2 and the Glucocorticoid Receptor within Rat Placenta Suggests Exquisite Local Control of Glucocorticoid Action Endocrinology, April 1, 1998; 139(4): 1517 - 1523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kotelevtsev, M. C. Holmes, A. Burchell, P. M. Houston, D. Schmoll, P. Jamieson, R. Best, R. Brown, C. R. W. Edwards, J. R. Seckl, et al. 11beta -Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress PNAS, December 23, 1997; 94(26): 14924 - 14929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Gomez-Sanchez Editorial: First There Was One, Then Two . . . Why More 11{beta}-Hydroxysteroid Dehydrogenases? Endocrinology, December 1, 1997; 138(12): 5087 - 5088. [Full Text] [PDF]
|
|
|
|
|
|
R.-S. Ge, D. O. Hardy, J. F. Catterall, and M. P. Hardy Developmental Changes in Glucocorticoid Receptor and 11{beta}-Hydroxysteroid Dehydrogenase Oxidative and Reductive Activities in Rat Leydig Cells Endocrinology, December 1, 1997; 138(12): 5089 - 5095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sun, K. Yang, and J. R. G. Challis Differential Regulation of 11 {beta}-Hydroxysteroid Dehydrogenase Type 1 and 2 by Nitric Oxide in Cultured Human Placental Trophoblast and Chorionic Cell Preparation Endocrinology, November 1, 1997; 138(11): 4912 - 4920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-S. Ge, H.-B. Gao, V. L. Nacharaju, G. L. Gunsalus, and M. P. Hardy Identification of a Kinetically Distinct Activity of 11{beta}-Hydroxysteroid Dehydrogenase in Rat Leydig Cells Endocrinology, June 1, 1997; 138(6): 2435 - 2442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. White, T. Mune, and A. K. Agarwal 11{beta}-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess Endocr. Rev., February 1, 1997; 18(1): 135 - 156. [Abstract] [Full Text]
|
|
|
|
|
|
K. Sun, K. Yang, and J. R. G. Challis Differential Expression of 11{beta}-Hydroxysteroid Dehydrogenase Types 1 and 2 in Human Placenta and Fetal Membranes J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 300 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-B. Gao, R.-S. Ge, V. Lakshmi, A. Marandici, and M. P. Hardy Hormonal Regulation of Oxidative and Reductive Activities of 11{beta}-Hydroxysteroid Dehydrogenase in Rat Leydig Cells Endocrinology, January 1, 1997; 138(1): 156 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Davani, A. Khan, M. Hult, E. Martensson, S. Okret, S. Efendic, H. Jornvall, and U. C. T. Oppermann Type 1 11beta -Hydroxysteroid Dehydrogenase Mediates Glucocorticoid Activation and Insulin Release in Pancreatic Islets J. Biol. Chem., November 3, 2000; 275(45): 34841 - 34844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. S. Williams, V. Lyons, I. MacLeod, V. Rajan, G. J. Darlington, V. Poli, J. R. Seckl, and K. E. Chapman C/EBP Regulates Hepatic Transcription of 11beta -Hydroxysteroid Dehydrogenase Type 1. A NOVEL MECHANISM FOR CROSS-TALK BETWEEN THE C/EBP AND GLUCOCORTICOID SIGNALING PATHWAYS J. Biol. Chem., September 22, 2000; 275(39): 30232 - 30239. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
